Rothschild Investment LLC’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5K Buy
428
+343
+404% +$23.4K ﹤0.01% 1358
2026
Q1
$5.49K Sell
85
-70
-45% -$4.93K ﹤0.01% 2006
2025
Q4
$10.4K Sell
155
-1,065
-87% -$71.6K ﹤0.01% 1553
2025
Q3
$89.5K Buy
+1,220
New +$81K 0.01% 824
2025
Q2
– Sell
-195
Closed -$12.4K – 3093
2025
Q1
$12.4K Buy
195
+130
+200% +$7.55K ﹤0.01% 1121
2024
Q4
$3.11K Sell
65
-30
-32% -$1.54K ﹤0.01% 1553
2024
Q3
$5.44K Buy
95
+55
+138% +$3.15K ﹤0.01% 1269
2024
Q2
$2.09K Buy
40
+30
+300% +$1.32K ﹤0.01% 1382
2024
Q1
$407 Buy
+10
New +$375 ﹤0.01% 1436

Other funds holding HALO

Rothschild Investment LLC's HALO Position: Q2 2026 in Review

Rothschild Investment LLC increased its Halozyme (HALO) stake by 404% in Q2 2026, buying an estimated $23.4K and bringing the position to 428 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Rothschild Investment LLC first reported a position in HALO in Q1 2024 and has held it in 9 quarters since. The position peaked at $89.5K in Q3 2025. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Rothschild Investment LLC held 428 shares of Halozyme worth $33.5K as of Q2 2026.
  • Rothschild Investment LLC bought 343 Halozyme shares in Q2 2026, an estimated $23.4K.
  • Halozyme made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1358 holding.
  • Rothschild Investment LLC first reported a position in Halozyme in Q1 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Halozyme position peaked at $89.5K in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.